ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.46B
Enterprise Value2.65B
P/E Ratio116.38
PEG Ratio-2.29
Price/Sales Ratio2.38
Price/Book Ratio4.45
Enterprise/Revenue2.68
Enterprise/EBITDA15.45

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.02
Operating Margin0.08
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.06

Income Statement

Revenue870.79M
Revenue/Share3.54
Gross Profit586.75M
EBITDA171.79M
Net Income24.85M
Diluted EPS0.1

Balance Sheet

Total Cash137.61M
Total Cash/Share0.56
Total Debt393.16M
Total Debt/Equity0.89
Current Ratio0.98
Book Value Per Share2.11

Price History

52-Week Change-29.06
52-Week High15.2
52-Week Low7.69
Moving Average 50 Days10.82
Moving Average 200 Days11.05

Statistics

Average Volume14.77M
Shares Outstanding256.01M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.74
Last Split Factor6:5
Last Split DateJuly 08, 2016
AD